Hinge Health Class A (HNGE) closed at $108.10 on November 19, 2026, down 5.6% from the previous close, on volume of 1,588,397 shares (30-day average 1,825,130).
Data as of November 19, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 21, 2026 | Diagonal Call Spread | 18-Dec-26 : 15-Jan-27120 : 135 C | 2,450 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 18, 2026. See the largest for 5, 30, 60 and 90 days
Hinge Health reports record third quarter 2026 financial results
Business Wire (Mon, 2-Nov 4:05 PM ET)
Hinge Health to announce third quarter 2026 financial results on November 2, 2026
Business Wire (Mon, 5-Oct 12:00 PM ET)
Market Chameleon (Wed, 5-Aug 3:44 AM ET)
Hinge Health Delivers Record 2025 Growth With Expanding Margins and Robust Client Metrics
Market Chameleon (Wed, 11-Feb 5:37 AM ET)
HNGE Delivers Record Results: Revenue Up 51%, Margins Climb, and Member Growth Accelerates
Market Chameleon (Wed, 11-Feb 2:37 AM ET)
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
Hinge Health Class A trades on the NYSE stock market under the symbol HNGE.
As of November 19, 2026, HNGE stock price declined to $108.10 with 1,588,397 million shares trading.
HNGE has a beta of 1.19, meaning it tends to be more sensitive to market movements. HNGE has a correlation of 0.05 to the broad based SPY ETF.
HNGE has a market cap of $8.36 billion. This is considered a Mid Cap stock.
Last quarter Hinge Health Class A reported $235 million in Revenue and $.66 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.13.
The top ETF exchange traded funds that HNGE belongs to (by Net Assets): VTI, VB, IWM, VXF, IWO.
HNGE has outperformed the market in the last year with a return of +166.1%, while the SPY ETF gained +9.6%. In the last 3 month period, HNGE beat the market returning +22.5%, while SPY returned -6.5%. However, in the most recent 2 weeks HNGE has underperformed the stock market by returning -10.6%, while SPY returned -6.6%.
HNGE support price is $110.67 and resistance is $118.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HNGE shares will trade within this expected range on the day.